I kontrollerede kliniske studier af centrale neuropatiske smerter ses en 50% forbedring i smertescore, hos 22% af patienterne behandlet med pregabalin og hos 7% af patienterne behandlet med placebo.
In the controlled clinical trial in central neuropathic pain 22% of the Pregabalin treated patients and 7% of the patients on placebo had a 50% improvement in pain score.